ATE14837T1 - Pharmazeutische zusammensetzungen. - Google Patents

Pharmazeutische zusammensetzungen.

Info

Publication number
ATE14837T1
ATE14837T1 AT81902743T AT81902743T ATE14837T1 AT E14837 T1 ATE14837 T1 AT E14837T1 AT 81902743 T AT81902743 T AT 81902743T AT 81902743 T AT81902743 T AT 81902743T AT E14837 T1 ATE14837 T1 AT E14837T1
Authority
AT
Austria
Prior art keywords
drug
folic acid
pharmaceutical compositions
depressant
pharmaceutical composition
Prior art date
Application number
AT81902743T
Other languages
English (en)
Inventor
Alec James Coppen
Original Assignee
Alec James Coppen
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alec James Coppen filed Critical Alec James Coppen
Application granted granted Critical
Publication of ATE14837T1 publication Critical patent/ATE14837T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT81902743T 1981-10-05 1981-10-05 Pharmazeutische zusammensetzungen. ATE14837T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/GB1981/000218 WO1983001199A1 (en) 1981-10-05 1981-10-05 Pharmaceutical compositions
EP81902743A EP0089948B1 (de) 1981-10-05 1981-10-05 Pharmazeutische zusammensetzungen

Publications (1)

Publication Number Publication Date
ATE14837T1 true ATE14837T1 (de) 1985-08-15

Family

ID=10518816

Family Applications (1)

Application Number Title Priority Date Filing Date
AT81902743T ATE14837T1 (de) 1981-10-05 1981-10-05 Pharmazeutische zusammensetzungen.

Country Status (4)

Country Link
EP (1) EP0089948B1 (de)
AT (1) ATE14837T1 (de)
DE (1) DE3171821D1 (de)
WO (1) WO1983001199A1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2292238T3 (es) * 1998-04-24 2008-03-01 Scarista Limited Tratamiento de la depresion y preparaciones farmaceuticas para el mismo.

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE739613A (de) * 1968-10-03 1970-03-02
GB2072504B (en) * 1980-03-27 1983-10-26 Coppen A J Pharmaceutical compositions

Also Published As

Publication number Publication date
WO1983001199A1 (en) 1983-04-14
EP0089948B1 (de) 1985-08-14
DE3171821D1 (en) 1985-09-19
EP0089948A1 (de) 1983-10-05

Similar Documents

Publication Publication Date Title
IL80149A (en) Pharmaceutical compositions containing toluidide derivatives against graft-versus-host diseases and autoimmune diseases
MY101791A (en) New benzimidazole derivatives
MY101784A (en) Novel pharmacological compounds
UA42061C2 (uk) Фармацевтична композиція для перорального введення, що містить інгібітори протонного насоса
GR3017282T3 (en) Novel arylpyridazines, their manufacture, use and medicaments containing them.
ES8608864A1 (es) Un procedimiento para producir un preparado a modo de hojas
ES431675A1 (es) Un procedimiento para preparar compuestos de hexahidro-di- benzo(b,d) piran-9-ona.
DE69319440D1 (de) Herstellung von pharmazeutischen zusammensetzungen, die calcitonin enthalten
ES2091183T3 (es) Metodo para mejorar el sueño.
KR870002845A (ko) 식욕조절 및 위암억제용 조성물
SE8405588D0 (sv) New compounds
SE8600658D0 (sv) Novel composition of matter
MY102411A (en) Nasal solutions
IL102032A0 (en) 2-amino-5-cyano-1,4-dihydropyridines,their preparation and pharmaceutical compositions containing them
KR890004705A (ko) 항바이러스성 제제
ATE14837T1 (de) Pharmazeutische zusammensetzungen.
MY100780A (en) Azumolene dosage form.
MY101821A (en) Quinazolinediones and pyridopyrimidinediones
ATE47664T1 (de) Pharmazeutische dosierungseinheit.
GB1480441A (en) Compositions for treating nicotine poisoning
ATE55254T1 (de) Verminderung der toxischen wirkungen von anthrachinon-medikamenten.
JO1531B1 (en) New near-compounds
GB1454872A (en) Anticonvulsant
ES468750A1 (es) Un metodo para preparar una composicion veterinaria que com-prende trimetoprim y sulfaquinoxalina
NO964775L (no) Fast farmasöytisk adenosinholdig preparat

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee